Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs combined oral contraceptives for endometriosis-related pain
IRCT20230509058136N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dienogest in endometriosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Endometriosis-related pain intensity. Started Jun 2023; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20230509058136N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230509058136N1.